These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Fungal infections in ICU patients: epidemiology and the role of diagnostics. Morace G; Borghi E Minerva Anestesiol; 2010 Nov; 76(11):950-6. PubMed ID: 21102391 [TBL] [Abstract][Full Text] [Related]
63. [Diagnosis of invasive fungal infection: current status and future prospect]. Li RY Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1449-50. PubMed ID: 16061019 [No Abstract] [Full Text] [Related]
64. In situ hybridization for rRNA sequences in anatomic pathology specimens, applications for fungal pathogen detection: a review. Montone KT; Guarner J Adv Anat Pathol; 2013 May; 20(3):168-74. PubMed ID: 23574773 [TBL] [Abstract][Full Text] [Related]
65. Reverse line blot hybridization assay for identification of medically important fungi from culture and clinical specimens. Zeng X; Kong F; Halliday C; Chen S; Lau A; Playford G; Sorrell TC J Clin Microbiol; 2007 Sep; 45(9):2872-80. PubMed ID: 17634313 [TBL] [Abstract][Full Text] [Related]
66. Advances and challenges in management of invasive mycoses. Patterson TF Lancet; 2005 Sep 17-23; 366(9490):1013-25. PubMed ID: 16168784 [TBL] [Abstract][Full Text] [Related]
68. Rapid identification of fungal pathogens by rolling circle amplification using Fonsecaea as a model. Najafzadeh MJ; Sun J; Vicente VA; de Hoog GS Mycoses; 2011 Sep; 54(5):e577-82. PubMed ID: 21910759 [TBL] [Abstract][Full Text] [Related]
69. Evaluation of fluorescence in situ hybridisation (FISH) for the detection of fungi directly from blood cultures and cerebrospinal fluid from patients with suspected invasive mycoses. Da Silva RM; Da Silva Neto JR; Santos CS; Frickmann H; Poppert S; Cruz KS; Koshikene D; De Souza JV Ann Clin Microbiol Antimicrob; 2015 Jan; 14():6. PubMed ID: 25637361 [TBL] [Abstract][Full Text] [Related]
72. [Advances in non-cultured laboratory diagnosis for etiology of invasive fungal diseases]. Shi Y; Zhao JN Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jul; 42(7):500-505. PubMed ID: 31365965 [TBL] [Abstract][Full Text] [Related]
73. Laboratory Diagnostic Capacity for Fungal Infections in Nigerian Tertiary Hospitals: A Gap Analysis Survey. Osaigbovo II; Oladele RO; Orefuwa E; Akanbi OA; Ihekweazu C West Afr J Med; 2021 Nov; Vol. 38(11):1065-1071. PubMed ID: 34919363 [TBL] [Abstract][Full Text] [Related]
74. Challenges in Serologic Diagnostics of Neglected Human Systemic Mycoses: An Overview on Characterization of New Targets. Inácio MM; Cruz-Leite VRM; Moreira ALE; Mattos K; Paccez JD; Ruiz OH; Venturini J; de Souza Carvalho Melhem M; Paniago AMM; de Almeida Soares CM; Weber SS; Borges CL Pathogens; 2022 May; 11(5):. PubMed ID: 35631090 [TBL] [Abstract][Full Text] [Related]
75. [Molecular methods as a diagnostic tool for fungal infections and their prospect]. Makimura K Nihon Ishinkin Gakkai Zasshi; 2004; 45(2):59-62. PubMed ID: 15118660 [TBL] [Abstract][Full Text] [Related]
76. Identification of Mycoses in Developing Countries. Arastehfar A; Wickes BL; Ilkit M; Pincus DH; Daneshnia F; Pan W; Fang W; Boekhout T J Fungi (Basel); 2019 Sep; 5(4):. PubMed ID: 31569472 [TBL] [Abstract][Full Text] [Related]